추천 제품
생물학적 소스
synthetic (organic)
Quality Level
Agency
USP/NF
meets USP testing specifications
분석
98.5-101.5% dry basis
형태
crystals
색상
white
mp
128-131 °C (lit.)
응용 분야
pharmaceutical (small molecule)
SMILES string
NC(=O)c1cccnc1
InChI
1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)
InChI key
DFPAKSUCGFBDDF-UHFFFAOYSA-N
유전자 정보
human ... PARP1(142) , SIRT2(22933)
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
Niacinamide, also known as 3-pyridinecarboxamide, is a water soluble vitamin. It is widely present in plants, animal food and cosmetics.
애플리케이션
Niacinamide has been used:
- as a component of islet maturation culture media
- to induce differentiation of insulin secreting cells
- to compare its preclinical effectiveness with that of progesterone
생화학적/생리학적 작용
Niacinamide is a primary precursor of nicotinamide adenine dinucleotide (NAD+), which is an important coenzyme in adenosine triphosphate (ATP) production. Nicotinamide deficiency is associated with pellagra.
Nicotinamide is an amide derivative of vitamin B3 and a PARP inhibitor
신호어
Warning
유해 및 위험 성명서
Hazard Classifications
Eye Irrit. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point (°F)
302.0 °F - closed cup
Flash Point (°C)
150 °C - closed cup
개인 보호 장비
dust mask type N95 (US), Eyeshields, Gloves
이미 열람한 고객
Stimulatory Role of Glycated Fetal Bovine Serum Along with Iron on In Vitro Production of Insulin by Differentiated Mouse Embryonic Stem Cells
Journal of Health Science, 57(4), 356-361 (2011)
A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat
Journal of Neurotrauma, 29(18), 2823-2830 (2012)
Necrostatin-1 supplementation enhances young porcine islet maturation and in vitro function
Xenotransplantation (2019)
Role of nicotinamide in DNA damage, mutagenesis, and DNA repair
Journal of Nucleic Acids, 2010 (2010)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(32), 4067-4075 (2013-10-02)
Open-label, phase III trial evaluating whether sunitinib was superior or equivalent to sorafenib in hepatocellular cancer. Patients were stratified and randomly assigned to receive sunitinib 37.5 mg once per day or sorafenib 400 mg twice per day. Primary end point
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.